-- 週五,美國股市指數大幅上漲,標普500指數和納斯達克綜合指數均創下歷史新高,而原油期貨價格則大幅下跌,因為市場對伊朗週末達成和平協議的預期日益增強。 那斯達克指數上漲1.5%,收在24,468.48點;標普500指數上漲1.2%,收在7,126.06點;道瓊工業指數上漲1.8%,收在49,447.43點。 西德州中質原油期貨價格暴跌11%,至每桶84.68美元;布蘭特原油期貨價格暴跌8.8%,至每桶90.69美元。 彭博社報道稱,美國總統川普表示,伊朗已同意無限期暫停其核子計劃,並且不會收到美國凍結的任何資金。 Axios週五報告稱,美國可能解凍200億美元的伊朗資金,以換取伊朗交出濃縮鈾庫存。 根據彭博社報道,川普週五在電話採訪中表示,結束戰爭的協議已基本完成。報道稱,總統表示,關於達成持久協議的談判「可能」將在本週末舉行。美伊停火將於下週結束,這意味著可能無需延長停火。 當天早些時候,伊朗宣佈在停火期剩餘時間內重新開放霍爾木茲海峽。 伊朗外長賽義德·阿巴斯·阿拉格奇在X網站上發帖稱:「根據黎巴嫩停火協議,所有商船在剩餘的停火期內均可完全通過霍爾木茲海峽,航行路線將按照伊朗伊斯蘭共和國港口和海事組織此前公佈的協調路線進行。」以色列和黎巴嫩之間為期10天的停火於週四生效。 根據美國有線電視新聞網(CNN)報道,川普週五也表示,美國對伊朗的海上封鎖將繼續,直到與伊朗達成的協議「100%完成」。 斯蒂費爾證券的一份研究報告指出:“對市場而言,唯一重要的戰爭變量是石油能否繼續通過霍爾木茲海峽流動。因此,今天宣布霍爾木茲海峽在剩餘的停火期內‘對航運開放’意義重大。” 由於原油價格下跌抑制了通膨擔憂,大多數美國公債殖利率下降,其中10年期公債殖利率下跌6.5個基點至4.25%,2年期公債殖利率下跌7.8個基點至3.7%。貴金屬方面,黃金期貨上漲1.3%至每盎司4,868.1美元,白銀期貨上漲3.2%至每盎司81.24美元。 除能源和公用事業板塊外,所有板塊盤中均大幅上漲。非必需消費品、工業及科技板塊領漲。 航空和郵輪板塊領漲標普500指數。皇家加勒比海航空(RCL)、聯合航空(UAL)和嘉年華郵輪(CCL)表現最佳,漲幅都至少達7%。雪佛龍(CVX)下跌2.2%,是道瓊指數中表現最差的股票。 在公司新聞方面,Netflix (NFLX) 股價下跌 9.7%,成為標普 500 指數和納斯達克指數中表現最差的股票之一。此前,該公司週四晚間發布了低於市場預期的第二季業績指引。這家串流媒體公司還表示,其董事長兼聯合創始人里德·哈斯廷斯計劃在 6 月任期結束後卸任。
Related Articles
Oneview Healthcare Reports Decline in Q1 Cash Receipts From Customers; Shares Up 3%
Oneview Healthcare (ASX:ONE) reported cash receipts from customers of about 3.3 million euros for the first quarter, compared with 4.2 million euros a year earlier, according to a Monday filing with the Australian bourse.The company noted that the year-ago figure includes two large customer receipts totaling more than 2 million euros, which were due to be received during the fourth quarter of 2024 but were received in early 2025.Oneview Healthcare ended March with a cash balance of AU$17.1 million, up from AU$8.1 million at the close of 2025, per the filing.The company's shares gained 3% in recent Monday trade.
Paradigm to Advance Participants Through Day 112 Follow-Up Period in Phase Three Knee Osteoarthritis Trial, Shares Reach One-Year Low
Paradigm Biopharmaceuticals (ASX:PAR) is set to progress participants through the day 112 follow-up period for the phase three trial evaluating injectable pentosan polysulfate sodium for the treatment of pain associated with knee osteoarthritis in the June quarter, which is required for inclusion in the interim analysis dataset, according to a Monday Australian bourse filing.The independent statistical analysis results for the data set are expected around August. Timing remains subject to the scheduling and review processes of independent third parties, and there is a reasonable likelihood that final interim outcomes may extend into September, it cautioned.The interim analysis is expected to provide the first phase three evaluation of efficacy and safety for injectable pentosan polysulfate sodium in knee osteoarthritis. Primary endpoint top-line results are expected in the March 2027 quarter.Its shares fell 14% in recent trading on Monday, reaching their lowest point in over a year.
Sanan Optoelectronics Q1 Profit Down 68%, Revenue Slides 33%
Sanan Optoelectronics (SHA:600703) posted first-quarter attributable net profit of 67.5 million yuan, down 68% from 211.9 million yuan the previous year.Earnings per share declined to 0.01 yuan from 0.04 yuan, according to a weekend filing with the Shanghai bourse.Operating revenue declined 33% year over year to 2.91 billion yuan from 4.31 billion yuan.Shares of the software company declined 2% in recent trade.